AC

Alex Charles Fernandes

Active Director Director DIN 02417576
DIN 02417576 First appointment Feb 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Feb 2009
Shareholding value •••• Premium profile

About Alex Charles Fernandes

Data last updated:

Alex Charles Fernandes is a Director at Alice Pharma Private Limited (since 2010), Director at Shamal Healthcare Private Limited (since 2019) and Director at Myra Healthcare Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹22.18 Cr; the largest is Alice Pharma Private Limited at ₹21.91 Cr (FY 2025). Earlier, Alex Charles Fernandes was a Director at Ceza Formulations Private Limited (2014–2016) and Director at Mednext Pharma Private Limited (2009–2015).

DIN 02417576
Primary Designation Director
Industry Pharma
First Appointment 03 Feb 2009
Oldest Company Age 19 yrs
Largest company Alice Pharma Private Limited · ₹21.91 Cr (FY 2025)
Combined revenue ₹22.18 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alice Pharma Private Limited U24232MP2006PTC019099
Director25 Nov 20102006₹21.91 Cr (FY 2025)Active
Shamal Healthcare Private Limited U70100MH2019PTC332775
Director08 Nov 20192019₹26.8 Lakh (FY 2025)Active
Myra Healthcare Private Limited U24110MH2020PTC336286
Director20 Jan 20202020₹1,050 (FY 2023)Active
Futura Lifecare Private Limited U24304MP2019PTC050500
Director27 Dec 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ceza Formulations Private Limited U24232MP1999PTC013421
Director13 Dec 20141999₹3.60 Cr (FY 2024)Active
Mednext Pharma Private Limited U24110MH2009PTC190076
Director03 Feb 20092009₹2.56 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alice Pharma Private Limited
Futura Lifecare Private Limited
Shamal Healthcare Private Limited
Myra Healthcare Private Limited
Premium access

Shareholding and investment profile for Alex Charles Fernandes

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alex Charles Fernandes

Alex Charles Fernandes currently holds 4 directorships: Alice Pharma Private Limited (Director, since 25 Nov 2010, revenue ₹21.91 Cr (FY 2025)); Shamal Healthcare Private Limited (Director, since 08 Nov 2019, revenue ₹26.8 Lakh (FY 2025)); Myra Healthcare Private Limited (Director, since 20 Jan 2020, revenue ₹1,050 (FY 2023)); Futura Lifecare Private Limited (Director, since 27 Dec 2019).

Alex Charles Fernandes was first appointed on 03 Feb 2009 as Director at Mednext Pharma Private Limited. The most recent appointment on record is 20 Jan 2020 at Myra Healthcare Private Limited.

The 3 current companies of Alex Charles Fernandes that report revenue have a combined latest revenue of ₹22.18 Cr: Alice Pharma Private Limited ₹21.91 Cr (FY 2025); Shamal Healthcare Private Limited ₹26.8 Lakh (FY 2025); Myra Healthcare Private Limited ₹1,050 (FY 2023).

Alex Charles Fernandes held 2 earlier board appointments: Ceza Formulations Private Limited (Director, 13 Dec 2014 to 18 Aug 2016); Mednext Pharma Private Limited (Director, 03 Feb 2009 to 12 Oct 2015).

The current boards of Alex Charles Fernandes's companies include Anil Kumar Vyas (Alice Pharma Private Limited), Leena Alex Fernandes (Alice Pharma Private Limited), Neelam Vyas (Alice Pharma Private Limited), Malaika Alex Fernandes (Myra Healthcare Private Limited), Sharon Alex Fernandes (Myra Healthcare Private Limited), Jitendra Paliwal (Futura Lifecare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available